We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
-0.54%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.55B
AUM Growth
+$1.66B
Cap. Flow
+$1.48B
Cap. Flow %
41.7%
Top 10 Hldgs %
32.7%
Holding
1,519
New
774
Increased
208
Reduced
176
Closed
301
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEV
1101
DELISTED
The Lion Electric Company
LEV
$43.8K ﹤0.01%
+48,200
New +$51.1K
BRBS icon
1102
Blue Ridge Bankshares
BRBS
$313M
$43K ﹤0.01%
+16,478
New +$46K
DLTH icon
1103
Duluth Holdings
DLTH
$152M
$40.6K ﹤0.01%
+11,000
New +$46.4K
CUE icon
1104
Cue Biopharma
CUE
$118M
$40.4K ﹤0.01%
+1,087
New +$53.8K
SPWR
1105
DELISTED
SunPower Corporation Common Stock
SPWR
$39.5K ﹤0.01%
+13,338
New +$36.4K
BLDR icon
1106
Builders FirstSource
BLDR
$7.29B
$38.5K ﹤0.01%
278
-3,107
-92% -$527K
XYZ
1107
Block Inc
XYZ
$48.9B
$37.5K ﹤0.01%
582
-9,783
-94% -$684K
SNAP icon
1108
Snap
SNAP
$7.96B
$37K ﹤0.01%
2,230
-6,244
-74% -$89.6K
HTZ icon
1109
CALL
Hertz
HTZ
$527M
$35.3K ﹤0.01%
+10,000
New +$50.8K
VOR icon
1110
Vor Biopharma
VOR
$1.06B
$35.1K ﹤0.01%
+1,755
New +$56.8K
NE icon
1111
Noble Corp
NE
$6.54B
$33.8K ﹤0.01%
757
KZR
1112
DELISTED
Kezar Life Sciences
KZR
$33.6K ﹤0.01%
+5,606
New +$42.6K
W icon
1113
Wayfair
W
$11.8B
$33.5K ﹤0.01%
636
+530
+500% +$31.5K
CUTR
1114
DELISTED
Cutera, Inc.
CUTR
$32.6K ﹤0.01%
+21,582
New +$43.4K
TW icon
1115
Tradeweb Markets
TW
$23B
$32.2K ﹤0.01%
+304
New +$32.1K
BTAI icon
1116
BioXcel Therapeutics
BTAI
$24.8M
$29.5K ﹤0.01%
+1,441
New +$48.2K
IOT icon
1117
Samsara
IOT
$22.6B
$28.9K ﹤0.01%
+859
New +$29.6K
DFLI icon
1118
Dragonfly Energy
DFLI
$15.5M
$28.5K ﹤0.01%
+374
New +$29K
WHWK
1119
Whitehawk Therapeutics
WHWK
$181M
$27.8K ﹤0.01%
+19,019
New +$35.2K
CTXR icon
1120
Citius Pharmaceuticals
CTXR
$15.6M
$27.8K ﹤0.01%
+1,902
New +$34.1K
SLB icon
1121
SLB Ltd
SLB
$72.7B
$24.7K ﹤0.01%
523
-21
-4% -$1.01K
HOWL icon
1122
Werewolf Therapeutics
HOWL
$22.4M
$24.5K ﹤0.01%
+10,043
New +$48.2K
ALNY icon
1123
PUT
Alnylam Pharmaceuticals
ALNY
$38.3B
$24.3K ﹤0.01%
+100
New +$15.8K
CCO icon
1124
Clear Channel Outdoor Holdings
CCO
$1.22B
$24.3K ﹤0.01%
+17,200
New +$25.4K
IMRX icon
1125
Immuneering
IMRX
$262M
$23.3K ﹤0.01%
+18,203
New +$29.9K

Similar funds

Paloma Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Paloma Partners held 1,519 positions worth $3.55B, up 88% from $1.89B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Paloma Partners deployed $1.48B of net new capital in Q2 2024, opening 774 new positions and adding to 208 existing holdings. Its largest new stake was Invesco QQQ Trust: 58,229 shares worth $27.9M.

By sector, the portfolio is most concentrated in Industrials at 3.8% of assets, up from 3% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P Metals & Mining ETF, an estimated $11M trimmed.

  • Paloma Partners's largest Q2 2024 buy was Invesco QQQ Trust: 58,229 shares worth $27.9M.
  • Paloma Partners added most to ConocoPhillips in Q2 2024, an estimated $12.6M increase.
  • Paloma Partners's biggest Q2 2024 reduction was State Street SPDR S&P Metals & Mining ETF, cutting an estimated $11M.
  • Paloma Partners fully exited Callon Petroleum Company in Q2 2024, selling an estimated $39.2M.
  • Paloma Partners's ten largest holdings make up 33% of its $3.55B portfolio in Q2 2024.
  • Paloma Partners opened 774 new positions and closed 301 in Q2 2024.
  • Paloma Partners's portfolio value rose 88% quarter-over-quarter to $3.55B.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.